Partial Nephrectomy Allowed By Anti CD 20 Antibody Treatment for Renal Cancer Associated with Acquired Haemophilia A

  title={Partial Nephrectomy Allowed By Anti CD 20 Antibody Treatment for Renal Cancer Associated with Acquired Haemophilia A},
  author={Tam{\'a}s Kullmann and Annick Ankri and Marc Olivier Bitker and Serge Herson and Olivier Benveniste},
  journal={Journal of Cancer Therapy},
The case of a forty-five year old woman is presented who consulted for spontaneous haematomas of the thighs. The diagnosis of acquired haemophilia A associated to renal cancer was retained. She received anti CD20 monoclonal antibody treatment allowing her to undergo partial nephrectomy 4 months later without major complication. One year after surgery there is no sign of tumour recurrence. 

Figures from this paper


Diagnosis, laboratory aspects and management of acquired hemophilia A
Factor VIII bypassing agents, such as prothrombin complex concentrates or recombinant activated factor VII, have proven effective in bleeding control, whereas the combined therapy of cyclophosphamide and corticosteroids seems to be, at present, the best immunosuppressive option.
The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders.
The results suggest that rituximab can be useful in the treatment of disorders of hemostasis associated with inhibitor formation, and large, prospective, randomized trials are needed to confirm the positive, preliminary results.
Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab
A 66-year old male AHA-patient successfully treated with single low-dose rituximab is reported, which demonstrates that complete B-cell depletion can be achieved with low- dose ritUXimab in AHA and restricts the administered dose to the lowest effective level.
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Treatment guidance for acquired hemophilia A is provided, based on collective clinical experience in treating patients with AHA, to contribute to improved care for this patient group.
Acquired Haemophilia A: A Concise Review
  • American Journal of Hematology, Vol. 80, No. 1, 2005, pp. 55-63. doi:10.3324/haematol.2009.017749
  • 2005